Verucide Physician Formula
Product Images NDC 63347-700

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Verucide Physician Formula (NDC 63347-700). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blaine Labs Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Verucide Bottle Labels (Blaine Verucide Bottles)

Verucide Bottle Labels (Blaine Verucide Bottles)
The text appears to be instructions related to some kind of medical product called "wart Remoye" by "PHYSICIAN FORMULA". The instructions contain two steps, Step 1 and Step 2 with corresponding directions for each step to use the product. The product is intended to be used to treat warts by dabbing or applying drops on the affected area. The text also includes an address in Santa Fe Springs, CA and a reference number.*
FDA Label Image

Verucide Box Label (Blaine Verucide Main)

Verucide Box Label (Blaine Verucide Main)
This product is a 2-step wart treatment system that includes a pre-treatment solution and a wart removal solution. The pre-treatment solution must be used to wash the affected area with one or two drops, while the wart removal solution should be dabbed onto the wart and allowed to dry. The treatment must be repeated once daily until the wart is gone. It is advised to keep out of reach of children, avoid contact with eyes, and not to inhale vapors. The manufacturer recommends seeing a doctor if discomfort persists and to call the Poison Control Center if swallowed. This treatment system is designed for common and plantar warts, and not to be applied to irritated skin or other body areas like moles, birthmarks, or genital warts. If one has diabetes or poor blood circulation, they should consult a physician before use.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.